share_log

Why Bluebird Bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket

Why Bluebird Bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket

为什么Bluebird Bio的交易价格上涨了约19%;以下是31只股票在盘前走势
Benzinga Real-time News ·  2022/09/19 06:54
Gainers
赢家
FOXO Technologies Inc. (NYSE:FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday. Amprius Technologies, Inc. (NYSE:AMPX) shares rose 20.5% to $10.00 in pre-market trading after declining 17% on Friday. bluebird bio, Inc. (NASDAQ:BLUE) rose 18.5% to $7.52 in pre-market trading. bluebird bio disclosed that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease. NexImmune, Inc. (NASDAQ:NEXI) rose 15.6% to $0.76 in pre-market trading. NexImmune and Selexis recently signed a service agreement to develop cell lines targeting rare cancers and autoimmune diseases. Secoo Holding Limited (NASDAQ:SECO) rose 14% to $0.3999 in pre-market trading...
福克斯科技公司(纽约证券交易所股票代码:FOXO)在周五下跌52%后,在盘前交易中上涨161%,至10.50美元。 安普瑞斯技术公司纽约证券交易所(NYSE:AMPX)股价在周五下跌17%后,在盘...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发